EMERGING PROGRAM “Our philosophy is to take science from the laboratory to the patient care arena,” says Chandan Sen, PhD, who also is vice chair for research in the OSU Department of Surgery and deputy director of the OSU Davis Heart and Lung Research Institute. He notes that chronic wound healing is an $8 billion industry nationwide; in 2004, Sen was recruited to Sen and colleagues in the Department of Surgery are leading a multicenter “Gene Screen” study that searches for biological clues – hidden in the genomics of blood vessels – about why some wounds heal and some do not. This study, which will screen the human genome to identify patterns of gene expression in vascular cells, is being conducted in partnership with National Healing Corporation (NHC), a private Florida-based company that manages 20 percent of the nation’s wound-healing centers, logging 250,000 patient visits per year. Sen says wound healing has several dimensions, but one of the fundamental obstacles to healing is insufficient oxygen. “When blood vessels at the wound site have been damaged or destroyed,” he explains, “you can put in whatever growth factors, such as cytokines, that you want, and you can do tissue grafts and apply other treatments, but if the wound is not properly oxygenated, healing runs out of gas.” Sen and colleagues at OSU and the “This study sets a new paradigm supporting the role of reactive oxygen species as a signal for repair,” Sen says, adding that the findings also underscore the importance of ensuring that wounds are properly oxygenated. Sen has been collaborating with OSU scientists Jay Zweier, MD, professor of Internal Medicine and director of the OSU Davis Heart and Lung Research Institute, and Periannan Kuppusamy, PhD, professor of Internal Medicine, in developing oxygen-imaging capabilities that will allow clinicians to accurately and painlessly measure oxygen present at the wound site. |
